Uploaded February 2024 | Updated November 2026, 3 hours ago
Millions of Europeans face the daily challenge of living with brain diseases.
Regular assessments are key to adapt treatments to evolving symptoms and patient needs, enhancing their quality of life and optimizing care and rehabilitation.
The ALAMEDA project leverages digital tools and AI to revolutionize monitoring and treatment for brain disorders, focusing on Parkinson’s disease, multiple sclerosis, and stroke.
A patient’s status is reviewed during their annual or six-monthly neurology consultation. However, reporting invisible symptoms, like fatigue or cognitive impairments, can be challenging for patients. Also, due to the long period of time between outpatient visits, patients often attach more importance to recent events meaning the burden of symptoms may be forgotten or under-estimated.
ALAMEDA envisions a future where every heartbeat and step count. We collect and analyze patient-generated data, capturing changes in behaviors, sleep patterns, emotional wellbeing, motor and cognitive functions to deepen our understanding of brain disease progression.
Shared decision-making is pivotal in ALAMEDA. We engage patients, families, and healthcare providers to hear every voice.
Our local community groups in Greece, Italy, and Romania, comprise patients, clinicians, and caregivers, voicing the concerns of our end users. We delve into Parkinson's, multiple sclerosis, and stroke care journeys, designing a data collection protocol that addresses specific needs and preferences.
This results in a study design that combines continuous collection of patient-reported outcome measures and quarterly 1 to 2 week-long intense monitoring period.
ALAMEDA’s architecture, from data collection to analytics, adheres to the highest standards of robustness, privacy, and security.
Our AI Toolkit, a suite of advanced machine learning models and tools, decodes the dynamics and predictability of brain diseases.
Our expert dashboard offers professionals insights for understanding disease progression and personalizing patient care. By emphasizing interpretability and explainability in our algorithms, we employ a human-in-the-loop approach to make our results sound, robust and clinically relevant.
Our digital health innovation hub is a collaborative space open to the integration with 3rd party solutions, where researchers, clinicians and developers can access our toolkit, use our data sets and test our algorithms and tools.
By bridging diagnosis, monitoring and treatment, ALAMEDA paves the way for redesigning brain healthcare. Visit alamedaproject.eu to be part of this journey.
Millions of Europeans face the daily challenge of living with brain diseases.
Regular assessments are key to adapt treatments to evolving symptoms and patient needs, enhancing their quality of life and optimizing care and rehabilitation.
The ALAMEDA project leverages digital tools and AI to revolutionize monitoring and treatment for brain disorders, focusing on Parkinson’s disease, multiple sclerosis, and stroke.
A patient’s status is reviewed during their annual or six-monthly neurology consultation. However, reporting invisible symptoms, like fatigue or cognitive impairments, can be challenging for patients. Also, due to the long period of time between outpatient visits, patients often attach more importance to recent events meaning the burden of symptoms may be forgotten or under-estimated.
ALAMEDA envisions a future where every heartbeat and step count. We collect and analyze patient-generated data, capturing changes in behaviors, sleep patterns, emotional wellbeing, motor and cognitive functions to deepen our understanding of brain disease progression.
Shared decision-making is pivotal in ALAMEDA. We engage patients, families, and healthcare providers to hear every voice.
Our local community groups in Greece, Italy, and Romania, comprise patients, clinicians, and caregivers, voicing the concerns of our end users. We delve into Parkinson's, multiple sclerosis, and stroke care journeys, designing a data collection protocol that addresses specific needs and preferences.
This results in a study design that combines continuous collection of patient-reported outcome measures and quarterly 1 to 2 week-long intense monitoring period.
ALAMEDA’s architecture, from data collection to analytics, adheres to the highest standards of robustness, privacy, and security.
Our AI Toolkit, a suite of advanced machine learning models and tools, decodes the dynamics and predictability of brain diseases.
Our expert dashboard offers professionals insights for understanding disease progression and personalizing patient care. By emphasizing interpretability and explainability in our algorithms, we employ a human-in-the-loop approach to make our results sound, robust and clinically relevant.
Our digital health innovation hub is a collaborative space open to the integration with 3rd party solutions, where researchers, clinicians and developers can access our toolkit, use our data sets and test our algorithms and tools.
By bridging diagnosis, monitoring and treatment, ALAMEDA paves the way for redesigning brain healthcare. Visit alamedaproject.eu to be part of this journey.










